Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Assayag

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Thorax|October 7, 2020
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung diseaseAmy Po Yu Tsai, Seo Am Hur, Alyson Wong, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respirology (Carlton, Vic.)|March 4, 2024
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohortVeronica Marcoux, Stacey D Lok, Prosanta Mondal, et al.
Respiratory Research|July 9, 2021
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung diseaseTao Chen, Amy Po Yu Tsai, Seo Am Hur, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
The European Respiratory Journal|March 1, 2023
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based studyYet H Khor, Max Schulte, Kerri A Johannson, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Thorax|October 7, 2020
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung diseaseAmy Po Yu Tsai, Seo Am Hur, Alyson Wong, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respirology (Carlton, Vic.)|March 4, 2024
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohortVeronica Marcoux, Stacey D Lok, Prosanta Mondal, et al.
Respiratory Research|July 9, 2021
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung diseaseTao Chen, Amy Po Yu Tsai, Seo Am Hur, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
The European Respiratory Journal|March 1, 2023
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based studyYet H Khor, Max Schulte, Kerri A Johannson, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Pageof 7